Wednesday, February 02, 2022
BioSig Technologies (BSGM)
Everything To See Here
BioSig Technologies, Inc. is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. PURE EP is a computerized system designed to reveal the full range of cardiac signals and to provide physicians with signal clarity during procedures performed to address cardiac arrhythmias. The PURE EP System has received FDA 510(k) clearance and installed its first commercial sale in February 2021. The company looks to apply their unique bioelectronic technology across additional disease conditions, including nervous system disorders, auto-immune diseases, hypertension, and pain.
Gregory Aurand, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Initiating Coverage. BioSig Technologies, Inc. is commercializing a proprietary high-fidelity, low noise cardiac signal processing platform that we believe is a game-changing technology. Somewhat like viewing high-definition TVs vs. standard-definition sets, the PURE EP System, compared to current platforms, provides electrophysiologists (EPs) with advanced signal clarity during electrophysiology ablation procedures that target heart electrical signal misfires. We are initiating coverage.
Target market is high revenue electrophysiology arrhythmia procedures. Arrhythmias are a growing healthcare concern and ablation procedures to alleviate the problem are improving the situation. The PURE EP System, by improving clinical outcomes, can advance ablation as the standard of care. While PURE EP currently has FDA clearance, the company is also seeking to obtain CE Mark, expanding the …
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
